The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance

Ciprofloxacin (CIP) is used to treat Pseudomonas aeruginosa biofilm infections. We showed that the pathways of CIP-resistance development during exposure of biofilms and planktonic P. aeruginosa populations to subinhibitory levels of CIP depend on the mode of growth. In the present study, we analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Marwa N., Abdelsamad, Ahmed, Wassermann, Tina, Porse, Andreas, Becker, Janna, Sommer, Morten O. A., Høiby, Niels, Ciofu, Oana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381665/
https://www.ncbi.nlm.nih.gov/pubmed/32709907
http://dx.doi.org/10.1038/s41522-020-00138-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381665/
https://www.ncbi.nlm.nih.gov/pubmed/32709907
http://dx.doi.org/10.1038/s41522-020-00138-8

Ejemplares similares